Concepedia

Marat Alimzhanov

MA

Statistics

Publications

27

Citations

4K

H-Index

24

Active since

1995

Affiliations

AstraZeneca (United States)(Current)

University of Cologne

Harvard University

AstraZeneca (United Kingdom)

Engelhardt Institute of Molecular Biology

Marat Alimzhanov is an author at AstraZeneca (United States) specializing in life sciences, immunology, and pharmacology.

ORCID

Publications per year

1995–2019

27

Publications

27

Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer

Manfred Kraus, Marat Alimzhanov, Nikolaus Rajewsky et al. · Cell · 2004 · 571 citations · Full text

, , +11

B cell receptor signal strength determines B cell fate

Stefano Casola, Kevin L. Otipoby, Marat Alimzhanov et al. · Nature Immunology · 2004 · 556 citations

, , +10

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Michael Hedvat, Dennis Huszar, Andreas Herrmann et al. · Cancer Cell · 2009 · 529 citations · Full text

, , +9

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 409 citations

, , +17

Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice

Marat Alimzhanov, Dmitry V. Kuprash, Marie Kosco‐Vilbois et al. · Proceedings of the National Academy of Sciences · 1997 · 367 citations

, , +14

1–5 of 27